Celcuity (CELC) Return on Capital Employed Growth (3y) (2020 - 2025)
Celcuity (CELC) Return on Capital Employed Growth (3y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Celcuity |
4.14 Bn |
3.42 Bn |
- |
2,597.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
2,597.00 |
| Sep 30, 2025 |
-473.00 |
| Jun 30, 2025 |
-2,575.00 |
| Mar 31, 2025 |
-490.00 |
| Dec 31, 2024 |
-313.00 |
| Sep 30, 2024 |
47.00 |
| Jun 30, 2024 |
1,774.00 |
| Mar 31, 2024 |
-130.00 |
| Dec 31, 2023 |
3,155.00 |
| Sep 30, 2023 |
-2,510.00 |
| Jun 30, 2023 |
-1,932.00 |
| Mar 31, 2023 |
-1,683.00 |
| Dec 31, 2022 |
-2,698.00 |
| Sep 30, 2022 |
1,705.00 |
| Jun 30, 2022 |
2,365.00 |
| Mar 31, 2022 |
1,805.00 |
| Dec 31, 2021 |
2,296.00 |
| Sep 30, 2021 |
-996.00 |
| Jun 30, 2021 |
-3,116.00 |
| Mar 31, 2021 |
-1,971.00 |
